COPD

Kuhn B, Barjaktarevic I. Editorial: Understanding the impact of lung ventilation heterogeneity. Front Med Technol. 2024 Mar 4;6:1332958. doi: 10.3389/fmedt.2024.1332958. PMID: 38500568; PMCID: PMC10944995.

By sjmartinez • March 19, 2024

Wilgus ML, Merchant M. Clearing the Air: Understanding the Impact of Wildfire Smoke on Asthma and COPD. Healthcare (Basel). 2024 Jan 25;12(3):307. doi: 10.3390/healthcare12030307. PMID:[...]

By sjmartinez • February 11, 2024

Regan EA, Lowe ME, Make BJ, Curtis JL, Chen QG, Crooks JL, Wilson C, Oates GR, Gregg RW, Baldomero AK, Bhatt SP, Diaz AA, Benos[...]

By sjmartinez • January 3, 2024

Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Reply to Gan et al., to Calzetta et al., and to Poor. Am[...]

By sjmartinez • November 9, 2023

Koch AL, Shing TL, Namen A, Couper D, Smith B, Barr RG, Bhatt S, Putcha N, Baugh A, Saha AK, Ziedler M, Comellas A, Cooper[...]

By sjmartinez • November 7, 2023

Prieto-Centurion V, Holm KE, Casaburi R, Porszasz J, Basu S, Bracken NE, Gallardo R 3rd, Gonzalez V, Illendula SD, Sandhaus RA, Sullivan JL, Walsh LJ,[...]

By sjmartinez • November 3, 2023

Lauria M, Stiehl B, Santhanam A, O'Connell D, Naumann L, McNitt-Gray M, Raldow A, Goldin J, Barjaktarevic I, Low DA. An analysis of the regional[...]

By sjmartinez • October 16, 2023

Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment[...]

By sjmartinez • August 16, 2023

Hansel NN, Woo H, Koehler K, Gassett A, Paulin LM, Alexis N, Putcha N, Lorizio W, Fawzy A, Belz D, Sack C, Barr RG, Martinez[...]

By sjmartinez • August 1, 2023

Motahari A, Barr RG, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN, Kanner RE, Kazerooni EA, Lynch[...]

By sjmartinez • July 26, 2023